Publication | Open Access

Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors

UrologyHealth SciencesMedicineClinical TrialsPharmacotherapyCancer TreatmentProstatic DiseaseOncologyRadiation OncologyLong-term SurvivorsFinal Analysis